Main menu (press 'Enter')
Access to page content (press 'Enter')
Direct access to list of other websites (press 'Enter')

Committee on the Environment, Public Health and Food Safety

ENVICommittee meeting -15:06 / 18:00 - 16-12-2013
 
 
To receive the link of the clip by mail, please fill your email address here above.
 
 
(Read it)
 
 
 
 
Subject

Interact in Twitter using #TPD, #Tobacco and #Ecig
Agenda
  • Mon, 16 Dec 2013 15:00 - 18:30
    • 1.0 Adoption of agenda
    • 2.0 Chair’s announcements
    • 3.0 (ENVI/7/10173) Protection of species of wild fauna and flora by regulating trade therein (Recast)
    • 4.0 (ENVI/7/14658) Objection pursuant to Rule 88(2): placing on the market for cultivation, in accordance with Directive 2001/18/EC, of a maize product (Zea mays L., line 1507) genetically modified for resistance to certain lepidopteran pests
    • 5.0 (ENVI/7/13863) Discharge 2012: EU general budget - European Commission
    • 6.0 (ENVI/7/13875) Discharge 2012: European Environment Agency
    • 7.0 (ENVI/7/13881) Discharge 2012: European Medicines Agency
    • 8.0 (ENVI/7/13891) Discharge 2012: European Food Safety Authority
    • 9.0 (ENVI/7/13893) Discharge 2012: European Centre for Disease Prevention and Control (ECDC)
    • 10.0 (ENVI/7/14207) Discharge 2012 : Chemicals Agency
    • 11.0 (ENVI/7/13766) Prevention and management of the introduction and spread of invasive alien species
    • 12.0 (ENVI/7/13825) New psychoactive substances
    • 13.0 (ENVI/7/13822) Minimum provisions on the constituent elements of criminal acts and penalties in the field of illicit drug trafficking, as regards the definition of the term 'drug'
    • 14.0 (ENVI/7/14691) Cloning of animals
    • * * *
  • Tue, 17 Dec 2013 09:00 - 10:00
    • In camera
    • 15.0 Coordinators’ meeting
  • Tue, 17 Dec 2013 10:00 - 12:30
    • *** Electronic vote ***
    • 16.0 Vote on the results of negotiations pursuant to Rule 70(5)(ENVI/7/10167) Modalities for reaching the 2020 target to reduce CO2 emissions from new passenger cars
    • 17.0 Vote on the results of negotiations pursuant to Rule 70(5)(ENVI/7/12784) Amendment of Regulation (EU) No 528/2012 concerning the making available on the market and use of biocidal products
    • 18.0 Vote on the results of negotiations pursuant to Rule 70(5)(ENVI/7/10860) Access to Genetic Resources and the Fair and Equitable Sharing of Benefits Arising from their Utilization in the Union
    • 19.0 Vote on a corrigendum pursuant to Rule 216(ENVI/7/00135) Restriction of the use of certain hazardous substances in electrical and electronic equipment (recast version)
    • 20.0 (ENVI/7/14658) Objection pursuant to Rule 88(2): placing on the market for cultivation, in accordance with Directive 2001/18/EC, of a maize product (Zea mays L., line 1507) genetically modified for resistance to certain lepidopteran pests
    • 21.0 (ENVI/7/13158) Fees payable to the European Medicines Agency for the conduct of pharmacovigilance activities in respect of medicinal products for human use
    • *** End of electronic vote ***
    • 22.0 (ENVI/7/14381) Amendment to Directive 2003/87/EC establishing a scheme for greenhouse gas emission allowance trading within the Community, in view of the implementation by 2020 of an international agreement applying a single global market-based measure to international aviation emissions
    • 23.0 (ENVI/7/12229) EFSA opinion on the safety of human consumption of the artificial sweetener aspartame
    • 24.0 (ENVI/7/14828) Country of origin or place of provenance for fresh, chilled, and frozen meat of swine, sheep, goats and poultry
    • 25.0 Next meeting(s)
    • Next meeting(s) (CJ10(2014)0109_1) Thu, 9 Jan 2014
    • Next meeting(s) (ENVI(2014)0122_1) Wed, 22 Jan 2014
 
 
Disclaimer: The interpretation does not constitute an authentic record of proceedings.

The simultaneous interpretation of debates provided by the European Parliament serves only to facilitate communication amongst the participants in the meeting. It does not constitute an authentic record of proceedings.


Only the original speech or the revised written translation of that speech is authentic.


Where there is any difference between the simultaneous interpretation and the original speech (or the revised written translation of the speech), the original speech (or the revised written translation) takes precedence.


Unless expressly authorised by the European Parliament, the use of the recorded interpretation for any purpose other than that mentioned above is strictly prohibited.

   
URL of the video stream
 
Permanent url of this page
 
Contact and help